Kraemer R - Search Results

1

Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Schaad UB, Wedgwood-Krucko J, Guenin K, Buehlmann U, Kraemer R. Schaad UB, et al. Among authors: kraemer r. Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):858-65. doi: 10.1007/BF01963771. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2512129 Clinical Trial.

2

Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.

Schaad UB, Desgrandchamps D, Kraemer R. Schaad UB, et al. Among authors: kraemer r. Acta Paediatr Scand. 1986 Jan;75(1):128-38. doi: 10.1111/j.1651-2227.1986.tb10169.x. Acta Paediatr Scand. 1986. PMID: 3082103 Clinical Trial.

3

Ventilation inhomogeneities in patients with cystic fibrosis: which target lung function parameters offer valuable evaluation?

Kraemer R. Kraemer R. Respiration. 2014;87(6):459-61. doi: 10.1159/000362675. Epub 2014 May 1. Respiration. 2014. PMID: 24801562 No abstract available.

4

Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis.

Gisler FM, von Kanel T, Kraemer R, Schaller A, Gallati S. Gisler FM, et al. Among authors: kraemer r. Eur J Hum Genet. 2013 Apr;21(4):397-403. doi: 10.1038/ejhg.2012.181. Epub 2012 Aug 15. Eur J Hum Genet. 2013. PMID: 22892532 Free PMC article.

5

Pulmonary outcome prediction for cystic fibrosis patients.

Kraemer R, Thamrin C. Kraemer R, et al. Pediatr Pulmonol. 2010 Dec;45(12):1153-5. doi: 10.1002/ppul.21320. Pediatr Pulmonol. 2010. PMID: 20845499 No abstract available.

6

Long-term gas exchange characteristics as markers of deterioration in patients with cystic fibrosis.

Kraemer R, Latzin P, Pramana I, Ballinari P, Gallati S, Frey U. Kraemer R, et al. Respir Res. 2009 Nov 12;10(1):106. doi: 10.1186/1465-9921-10-106. Respir Res. 2009. PMID: 19909502 Free PMC article.

7

Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.

Kraemer R, Baldwin DN, Ammann RA, Frey U, Gallati S. Kraemer R, et al. Respir Res. 2006 Nov 30;7(1):138. doi: 10.1186/1465-9921-7-138. Respir Res. 2006. PMID: 17137500 Free PMC article.

8

Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.

Kraemer R, Deloséa N, Ballinari P, Gallati S, Crameri R. Kraemer R, et al. Am J Respir Crit Care Med. 2006 Dec 1;174(11):1211-20. doi: 10.1164/rccm.200603-423OC. Epub 2006 Sep 7. Am J Respir Crit Care Med. 2006. PMID: 16959918

9

Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.

Keller BM, Aebischer CC, Kraemer R, Schöni MH. Keller BM, et al. Among authors: kraemer r. J Cyst Fibros. 2003 Jun;2(2):76-83. doi: 10.1016/S1569-1993(03)00023-7. J Cyst Fibros. 2003. PMID: 15463854

10

Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis.

Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S. Kraemer R, et al. Am J Respir Crit Care Med. 2005 Feb 15;171(4):371-8. doi: 10.1164/rccm.200407-948OC. Epub 2004 Nov 5. Am J Respir Crit Care Med. 2005. PMID: 15531750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results